Skip to content

Drug interactions

Oxybutynin transdermal + Ribociclib

Severity: Minor

Oxybutynin transdermal and Ribociclib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Transdermal oxybutynin bypasses first-pass gut and liver metabolism, so CYP3A4 inhibition has much less effect on systemic oxybutynin exposure than with oral dosing. Clinically meaningful interaction is unlikely.

What this interaction means in plain words

Oxybutynin transdermal and Ribociclib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Theoretical CYP3A4 inhibition by ribociclib, blunted by transdermal delivery bypassing first-pass metabolism.

What to do

No dose adjustment is needed; monitor for anticholinergic effects such as dry mouth and constipation.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Oxybutynin transdermal and Ribociclib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Oxybutynin transdermal with Ribociclib?

MediHelp rates the interaction as minor. Oxybutynin transdermal and Ribociclib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Transdermal oxybutynin bypasses first-pass gut and liver metabolism, so CYP3A4 inhibition has much less effect on systemic oxybutynin exposure than with oral dosing. Clinically meaningful interaction is unlikely.

How serious is the interaction between Oxybutynin transdermal and Ribociclib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed; monitor for anticholinergic effects such as dry mouth and constipation.

What other medicines interact with Ribociclib?

MediHelp also lists interactions of Ribociclib with, for example, Amiodarone, Cisapride, Dofetilide. The full list is on the Ribociclib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in